- GlobeNewswire•15 hours agoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN
NEW YORK, Dec. 08, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Allergan plc and/or Actavis plc ...
- Investopedia•18 hours ago
Brent Saunders, AGN's CEO had much to say about drug pricing and acquisition possibilities.
- PR Newswire•18 hours agoAllergan Comments on PTAB Decision Regarding Mylan's Petitions for Inter Partes Review (IPR) of RESTASIS® Patents
DUBLIN, Dec. 8, 2016 /PRNewswire/ -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, today announced the U.S. Patent & Trademark Office's Patent Trial and Appeal Board (PTAB) granted ...
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||194.35 x 200|
|Ask||194.63 x 100|
|Day's Range||189.13 - 196.30|
|52 Week Range||184.50 - 317.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||5.47|
|Dividend & Yield||2.80 (1.46%)|
|1y Target Est||N/A|